Heron Therapeutics Inc [HRTX] Investment Guide: What You Need to Know
Heron Therapeutics Inc’s filing revealed that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17 ’23. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.21 million. Then, Collard Craig […]
Insider Buying: Forbes William P, Heron Therapeutics Inc [HRTX] EVP, Chief Development Officer invested 25,000 shares
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Heron Therapeutics Inc shares valued at $27,250 were purchased by Forbes William P on Nov 17 ’23. At $1.09 per share, Forbes William P acquired 25,000 shares. The insider’s holdings grew to 79,000 shares worth approximately $0.22 […]
HRTX’s latest rating updates from top analysts.
Heron Therapeutics Inc’s recent filing unveils that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17 ’23. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.23 million. Then, Collard […]
HRTX Shares Experience Decline in Value
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Heron Therapeutics Inc shares valued at $27,250 were purchased by Forbes William P on Nov 17 ’23. At $1.09 per share, Forbes William P acquired 25,000 shares. The insider’s holdings grew […]
Heron Therapeutics Inc (HRTX) receives a Buy rating from Needham
Heron Therapeutics Inc’s recent filing unveils that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17 ’23. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.22 million. Then, Collard […]
Heron Therapeutics Inc [HRTX] Records 200-Day SMA of $1.66
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Heron Therapeutics Inc shares valued at $27,250 were purchased by Forbes William P on Nov 17 ’23. At $1.09 per share, Forbes William P acquired 25,000 shares. The insider’s holdings grew […]
Heron Therapeutics Inc [HRTX] Investment Guide: What You Need to Know
In a filing, Heron Therapeutics Inc revealed its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17 ’23. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.22 million. Then, Collard […]
Heron Therapeutics Inc (HRTX) rating reiterates by Needham
Heron Therapeutics Inc’s filing revealed that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17 ’23. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.23 million. Then, Collard Craig […]
Heron Therapeutics Inc. (HRTX) stock rose during pre-market. Let’s find out why?
Heron Therapeutics Inc. (NASDAQ: HRTX) stock surged by 11.38% at last close while the HRTX stock price gains by 7.53% in the pre-market trading session. Heron Therapeutics is an advertising biotechnology business dedicated to improving patients’ lives by discovering best-in-class therapies for some of the most serious unmet medical needs. HRTX stock’ Significant Update The […]
